News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hepner Adrian
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/01/2023 |
4
| Hepner Adrian (Chief Medical Officer) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Granted 115,000 options to buy
@ $3.85, valued at
$442.8k
|
|
| 01/04/2023 |
4
| Hepner Adrian (Chief Medical Officer) has filed a Form 4 on Coya Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $0
Bought 5,000 options to buy
@ $7.5, valued at
$37.5k
|
|
| 12/28/2022 |
3
| Hepner Adrian (Chief Medical Officer) has filed a Form 3 on Coya Therapeutics, Inc. |
| 01/27/2020 |
4
| Hepner Adrian (EVP and Chief Medical Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,630 shares
@ $57.98, valued at
$94.5k
|
|
| 01/07/2020 |
4
| Hepner Adrian (EVP and Chief Medical Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 24,000 shares
@ $0
Paid exercise price by delivering 815 shares
@ $57.38, valued at
$46.8k
Granted 55,000 options to buy
@ $59.795, valued at
$3.3M
|
|
| 01/25/2019 |
4
| Hepner Adrian (EVP and Chief Medical Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 771 shares
@ $41.33, valued at
$31.9k
Granted 19,000 shares
@ $0
Granted 42,500 options to buy
@ $42.4, valued at
$1.8M
|
|
| 01/09/2018 |
4
| Hepner Adrian (EVP and Chief Medical Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 9,000 shares
@ $0
Granted 43,000 options to buy
@ $59.14, valued at
$2.5M
Granted 27,000 rights
@ $0 |
|
| 01/06/2017 |
4
| Hepner Adrian (EVP and Chief Medical Officer) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 67,200 options to buy
@ $84.92, valued at
$5.7M
|
|
|
|